Summary of ophthalmic diagnosis, duration and type of glaucoma medications, and history of previous allergy
| Patient No | Age, sex | Diagnosis | Concomitant topical bb and duration of Rx (months)† | Duration of Trusopt Rx (weeks) | Resolution after withdrawal of Trusopt | Previous adverse reaction to topical medication | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| POAG = primary open angle glaucoma, HZO = herpes zoster ophthalmia, PXF = pseudoexfoliation, OHT = ocular hypertension, Rx = treatment, bb = β blocker. | *Patients who underwent patch testing; †the time recorded is the duration of β blocker therapy before the introduction of dorzolamide. | ||||||||||||
| 1 | 77, M | POAG | Levobunolol (33) | 20 | No | None | |||||||
| 2 | 84, F | POAG | Betaxolol (12) | 20 | Yes | Neomycin | |||||||
| 3 | 75, F | HZO | Betaxolol (83) | 28 | Yes | Dipivefrin | |||||||
| 4 | 87, F | PXF | Levobunolol (33) | 8 | No | Dipivefrin | |||||||
| 5 | 74, M* | POAG | Timolol (58) | 8 | No | Chloramphenicol | |||||||
| 6 | 73, F | POAG | Levobunolol (30) | 36 | Yes | None | |||||||
| 7 | 66, M* | OHT | Betaxolol (32) | 24 | Yes | Dipivefrin | |||||||
| 8 | 83, F | POAG | Timolol (49) | 24 | Yes | None | |||||||
| 9 | 75, M* | POAG | Timolol (45) | 40 | No | Dipivefrin | |||||||
| 10 | 82, F* | POAG | Levobunolol (12) | 9 | Yes | None | |||||||
| 11 | 87, M | OHT | None | 4 | Yes | None | |||||||
| 12 | 58, M | OHT | Timolol (24) | 24 | No | Dipivefrin | |||||||
| 13 | 66, M* | POAG | Levobunolol (19) | 20 | No | None | |||||||
| 14 | 65, M* | POAG | Levobunolol (15) | 20 | Yes | None | |||||||